Literature DB >> 15485660

An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A.

Maryam Zarghooni1, Scott Bukovac, Michael Tropak, John Callahan, Don Mahuran.   

Abstract

The alpha- and/or beta-subunits of human beta-hexosaminidase A (alphabeta) and B (betabeta) are approximately 60% identical. In vivo only beta-hexosaminidase A can utilize GM2 ganglioside as a substrate, but requires the GM2 activator protein to bind GM2 ganglioside and then interact with the enzyme, placing the terminal GalNAc residue in the active site of the alpha-subunit. A model for this interaction suggests that two loop structures, present only in the alpha-subunit, may be critical to this binding. Three amino acids in one of these loops are not encoded in the HEXB gene, while four from the other are removed posttranslationally from the pro-beta-subunit. Natural substrate assays with forms of hexosaminidase A containing mutant alpha-subunits demonstrate that only the site that is removed from the beta-subunit during its maturation is critical for the interaction. Our data suggest an unexpected biological role for such proteolytic processing events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485660      PMCID: PMC2918538          DOI: 10.1016/j.bbrc.2004.09.159

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Crystal structure of human GM2-activator protein with a novel beta-cup topology.

Authors:  C S Wright; S C Li; F Rastinejad
Journal:  J Mol Biol       Date:  2000-12-01       Impact factor: 5.469

2.  Characterization of the Glu and Asp residues in the active site of human beta-hexosaminidase B.

Authors:  Y Hou; D J Vocadlo; A Leung; S G Withers; D Mahuran
Journal:  Biochemistry       Date:  2001-02-20       Impact factor: 3.162

3.  Characterization of the affinity of the G(M2) activator protein for glycolipids by a fluorescence dequenching assay.

Authors:  N Smiljanic-Georgijev; B Rigat; B Xie; W Wang; D J Mahuran
Journal:  Biochim Biophys Acta       Date:  1997-05-23

4.  Proteolytic processing of pro-alpha and pro-beta precursors from human beta-hexosaminidase. Generation of the mature alpha and beta a beta b subunits.

Authors:  D J Mahuran; K Neote; M H Klavins; A Leung; R A Gravel
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

5.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

6.  Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

7.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

8.  Identification of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase.

Authors:  R Sharma; H Deng; A Leung; D Mahuran
Journal:  Biochemistry       Date:  2001-05-08       Impact factor: 3.162

9.  A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.

Authors:  Rohita Sharma; Scott Bukovac; John Callahan; Don Mahuran
Journal:  Biochim Biophys Acta       Date:  2003-01-20

10.  Oligosaccharide structure and amino acid sequence of the major glycopeptides of mature human beta-hexosaminidase.

Authors:  B F O'Dowd; D A Cumming; R A Gravel; D Mahuran
Journal:  Biochemistry       Date:  1988-07-12       Impact factor: 3.162

View more
  10 in total

1.  A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates.

Authors:  Michael B Tropak; Scott W Bukovac; Brigitte A Rigat; Sayuri Yonekawa; Warren Wakarchuk; Don J Mahuran
Journal:  Glycobiology       Date:  2009-11-16       Impact factor: 4.313

2.  Thymic involution and corticosterone level in Sandhoff disease model mice: new aspects the pathogenesis of GM2 gangliosidosis.

Authors:  Kazuhiko Matsuoka; Daisuke Tsuji; Takao Taki; Kohji Itoh
Journal:  J Inherit Metab Dis       Date:  2011-05-20       Impact factor: 4.982

3.  Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease.

Authors:  Kazuhiko Matsuoka; Daisuke Tsuji; Sei-Ichi Aikawa; Fumiko Matsuzawa; Hitoshi Sakuraba; Kohji Itoh
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

4.  Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.

Authors:  Keisuke Kitakaze; Yasumichi Mizutani; Eiji Sugiyama; Chikako Tasaki; Daisuke Tsuji; Nobuo Maita; Takatsugu Hirokawa; Daisuke Asanuma; Mako Kamiya; Kohei Sato; Mitsutoshi Setou; Yasuteru Urano; Tadayasu Togawa; Akira Otaka; Hitoshi Sakuraba; Kohji Itoh
Journal:  J Clin Invest       Date:  2016-03-28       Impact factor: 14.808

5.  Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.

Authors:  M Joanne Lemieux; Brian L Mark; Maia M Cherney; Stephen G Withers; Don J Mahuran; Michael N G James
Journal:  J Mol Biol       Date:  2006-04-27       Impact factor: 5.469

6.  P. Ala278Val mutation might cause a pathogenic defect in HEXB folding leading to the Sandhoff disease.

Authors:  Zahra Rahmani; Arsham Banisadr; Vadieh Ghodsinezhad; Mohsen Dibaj; Omid Aryani
Journal:  Metab Brain Dis       Date:  2022-10-03       Impact factor: 3.655

7.  Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.

Authors:  Kazuhiko Matsuoka; Tomomi Tamura; Daisuke Tsuji; Yukie Dohzono; Keisuke Kitakaze; Kazuki Ohno; Seiji Saito; Hitoshi Sakuraba; Kohji Itoh
Journal:  Mol Ther       Date:  2011-04-12       Impact factor: 11.454

8.  Combined replacement effects of human modified β-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts.

Authors:  Keisuke Kitakaze; Chikako Tasaki; Youichi Tajima; Takatsugu Hirokawa; Daisuke Tsuji; Hitoshi Sakuraba; Kohji Itoh
Journal:  Biochem Biophys Rep       Date:  2016-06-08

9.  ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance.

Authors:  Li Jiang; Yajing Hao; Changwei Shao; Qiulian Wu; Briana C Prager; Ryan C Gimple; Gabriele Sulli; Leo Jy Kim; Guoxin Zhang; Zhixin Qiu; Zhe Zhu; Xiang-Dong Fu; Jeremy N Rich
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 19.456

10.  In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside.

Authors:  Incilay Sinici; Sayuri Yonekawa; Ilona Tkachyova; Steven J Gray; R Jude Samulski; Warren Wakarchuk; Brian L Mark; Don J Mahuran
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.